Overview
Citizens Q2 revenue of $65.1 mln beats analyst expectations, per LSEG data
Net income rises to $6.5 mln from $4.0 mln in Q2 2024
Co's direct insurance in force hits record $5.35 bln, up 4.4% yr/yr
Outlook
Citizens expects revenue and profit growth for full year 2026
Company highlights competitive advantages in expanding niche markets globally
Citizens sees positive outlook supported by robust global business model
Result Drivers
AGENT EXPANSION - Global network of producing agents increased by 53% since June 2024, boosting sales
NEW PRODUCTS - Highest-ever total direct insurance in force of $5.35 bln driven by new product sales
PREMIUM GROWTH - Direct first-year life and A&H premiums rose 20% in Q2 2025 compared to year-ago quarter
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$65.10 mln
$62.70 mln (2 Analysts)
Q2 Net Income
$6.50 mln
Analyst Coverage
The one available analyst rating on the shares is "strong buy"
The average consensus recommendation for the life & health insurance peer group is "buy."
Wall Street's median 12-month price target for Citizens Inc is $5.50, about 23.8% above its August 6 closing price of $4.19
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 12 three months ago
Press Release: ID:nNFC2h1SS
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)